Last reviewed · How we verify
FloSeal application
At a glance
| Generic name | FloSeal application |
|---|---|
| Sponsor | Asan Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of Collagen-Based Thrombin Hemostat for the Control of Bleeding in Spinal Surgery (NA)
- Evaluation of Hemostatic Agents in Partial Nephrectomy (NA)
- Trial of Modifications to Radical Prostatectomy (PHASE3)
- Efficacy Study of FloSeal in Hemostasis After Laparoscopic Ovarian Cystectomy (NA)
- Benefit of Hemostatic Sealant in Preservation of Ovarian Reserve (NA)
- Management of Persistent Epistaxis Using Floseal Hemostatic Matrix (NA)
- Combined Topical Tranexamic Acid With Floseal® in Total Knee Arthroplasty (PHASE4)
- Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FloSeal application CI brief — competitive landscape report
- FloSeal application updates RSS · CI watch RSS
- Asan Medical Center portfolio CI